Alector, Inc. Net Income
Alector, Inc. (ALEC) reported Net Income of -$22.99 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-06
- Alector, Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$22.99M.
- Alector, Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$22.93M.
- Alector, Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$37.34M.
- Alector, Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$34.67M.
- Alector, Inc. net income (loss) attributable to parent for fiscal 2022 was -$133.31M.
- Alector, Inc. net income (loss) attributable to parent for fiscal 2021 was -$36.33M.
- Alector, Inc. net income (loss) attributable to parent for fiscal 2020 was -$190.23M.
- Alector, Inc. net income (loss) attributable to parent for fiscal 2019 was -$105.39M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$22.99M 10-Q · filed 2026-08-06 | -$45.92M 10-Q · filed 2026-08-06 | -$83.26M derived: sum of 3 quarters · filed 2026-08-06 | -$117.92M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$22.93M 10-Q · filed 2026-08-06 | -$60.27M derived: sum of 2 quarters · filed 2026-08-06 | -$94.94M derived: sum of 3 quarters · filed 2026-08-06 | -$125.46M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$37.34M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-28 | -$72.00M derived: sum of 2 quarters · filed 2026-04-28 | -$102.53M derived: sum of 3 quarters · filed 2026-08-06 | -$143.00M DEF 14A · filed 2026-04-28 | -$142.93M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$34.67M 10-Q · filed 2025-11-06 | -$65.19M derived: sum of 2 quarters · filed 2026-08-06 | -$105.66M 10-Q · filed 2025-11-06 | -$107.69M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$30.52M 10-Q · filed 2026-08-06 | -$71.00M 10-Q · filed 2026-08-06 | -$73.02M derived: sum of 3 quarters · filed 2026-08-06 | -$115.24M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$40.47M 10-Q · filed 2026-08-06 | -$42.50M derived: sum of 2 quarters · filed 2026-08-06 | -$84.72M derived: sum of 3 quarters · filed 2026-08-06 | -$123.39M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-12-31 | -$2.02M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-28 | -$44.24M derived: sum of 2 quarters · filed 2026-04-28 | -$82.92M derived: sum of 3 quarters · filed 2026-04-28 | -$119.00M DEF 14A · filed 2026-04-28 | -$119.05M 10-K · filed 2025-02-26 |
| 2024-09-30 | -$42.22M 10-Q · filed 2025-11-06 | -$80.90M derived: sum of 2 quarters · filed 2025-11-06 | -$116.97M 10-Q · filed 2025-11-06 | -$158.02M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2024-06-30 | -$38.68M 10-Q · filed 2025-11-06 | -$74.75M 10-Q · filed 2025-08-07 | -$115.80M derived: sum of 3 quarters · filed 2026-04-28 | -$160.27M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2024-03-31 | -$36.08M 10-Q · filed 2025-11-06 | -$77.12M derived: sum of 2 quarters · filed 2026-04-28 | -$121.60M derived: sum of 3 quarters · filed 2026-04-28 | -$120.22M derived: sum of 4 quarters · filed 2026-04-28 | |
| 2023-12-31 | -$41.04M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-28 | -$85.52M derived: sum of 2 quarters · filed 2026-04-28 | -$84.14M derived: sum of 3 quarters · filed 2026-04-28 | -$130.00M DEF 14A · filed 2026-04-28 | -$130.39M 10-K · filed 2024-02-27 |
| 2023-09-30 | -$44.48M 10-Q · filed 2024-11-06 | -$43.10M derived: sum of 2 quarters · filed 2024-11-06 | -$88.96M 10-Q · filed 2024-11-06 | -$141.38M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-06-30 | $1.38M 10-Q · filed 2024-11-06 | -$44.48M 10-Q · filed 2024-08-07 | -$96.91M derived: sum of 3 quarters · filed 2025-02-26 | -$143.06M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2023-03-31 | -$45.86M 10-Q · filed 2024-11-06 | -$98.28M derived: sum of 2 quarters · filed 2025-02-26 | -$144.43M derived: sum of 3 quarters · filed 2025-02-26 | -$134.55M derived: sum of 4 quarters · filed 2025-02-26 | |
| 2022-12-31 | -$52.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$98.58M derived: sum of 2 quarters · filed 2025-02-26 | -$88.69M derived: sum of 3 quarters · filed 2025-02-26 | -$133.31M 10-K · filed 2025-02-26 | |
| 2022-09-30 | -$46.15M 10-Q · filed 2023-11-07 | -$36.27M derived: sum of 2 quarters · filed 2023-11-07 | -$80.88M 10-Q · filed 2023-11-07 | -$136.49M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $9.88M 10-Q · filed 2023-11-07 | -$34.73M 10-Q · filed 2023-08-03 | -$90.34M derived: sum of 3 quarters · filed 2024-02-27 | $36.26M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | -$44.62M 10-Q · filed 2023-11-07 | -$100.22M derived: sum of 2 quarters · filed 2024-02-27 | $26.37M derived: sum of 3 quarters · filed 2024-02-27 | -$28.77M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | -$55.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $70.99M derived: sum of 2 quarters · filed 2024-02-27 | $15.84M derived: sum of 3 quarters · filed 2024-02-27 | -$36.33M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $126.60M 10-Q · filed 2022-11-08 | $71.45M derived: sum of 2 quarters · filed 2022-11-08 | $19.28M 10-Q · filed 2022-11-08 | -$32.90M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | -$55.15M 10-Q · filed 2022-11-08 | -$107.32M 10-Q · filed 2022-08-04 | -$159.50M derived: sum of 3 quarters · filed 2023-02-28 | -$212.20M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | -$52.17M 10-Q · filed 2022-11-08 | -$104.35M derived: sum of 2 quarters · filed 2023-02-28 | -$157.05M derived: sum of 3 quarters · filed 2023-02-28 | -$202.38M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$52.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$104.88M derived: sum of 2 quarters · filed 2023-02-28 | -$150.21M derived: sum of 3 quarters · filed 2023-02-28 | -$190.23M 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$52.70M 10-Q · filed 2021-11-04 | -$98.03M derived: sum of 2 quarters · filed 2021-11-04 | -$138.05M 10-Q · filed 2021-11-04 | -$168.58M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-06-30 | -$45.33M 10-Q · filed 2021-11-04 | -$85.34M 10-Q · filed 2021-08-03 | -$115.87M derived: sum of 3 quarters · filed 2021-11-04 | -$147.61M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2020-03-31 | -$40.02M 10-Q · filed 2021-11-04 | -$70.55M derived: sum of 2 quarters · filed 2021-11-04 | -$102.28M derived: sum of 3 quarters · filed 2021-11-04 | -$126.84M derived: sum of 4 quarters · filed 2021-11-04 | |
| 2019-12-31 | -$30.53M 10-K · filed 2020-03-24 | -$62.27M derived: sum of 2 quarters · filed 2020-11-10 | -$86.83M derived: sum of 3 quarters · filed 2020-11-10 | -$105.39M 10-K · filed 2022-02-24 | |
| 2019-09-30 | -$31.74M 10-Q · filed 2020-11-10 | -$56.30M derived: sum of 2 quarters · filed 2020-11-10 | -$74.86M 10-Q · filed 2020-11-10 | -$92.23M derived: sum of 4 quarters · filed 2020-11-10 | |
| 2019-06-30 | -$24.56M 10-Q · filed 2020-11-10 | -$43.12M 10-Q · filed 2020-08-11 | -$60.49M derived: sum of 3 quarters · filed 2020-11-10 | -$75.81M derived: sum of 4 quarters · filed 2020-11-10 | |
| 2019-03-31 | -$18.56M 10-Q · filed 2020-11-10 | -$35.93M derived: sum of 2 quarters · filed 2020-11-10 | -$51.25M derived: sum of 3 quarters · filed 2020-11-10 | -$62.37M derived: sum of 4 quarters · filed 2020-11-10 | |
| 2018-12-31 | -$17.37M 10-K · filed 2020-03-24 | -$32.69M derived: sum of 2 quarters · filed 2020-03-24 | -$43.81M derived: sum of 3 quarters · filed 2020-03-24 | -$52.25M 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$15.32M 10-K · filed 2020-03-24 | -$26.44M derived: sum of 2 quarters · filed 2020-03-24 | -$34.88M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$11.12M 10-K · filed 2020-03-24 | -$19.56M 10-Q · filed 2019-08-12 | |||
| 2018-03-31 | -$8.44M 10-K · filed 2020-03-24 | ||||
| 2017-12-31 | -$32.48M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |